首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Unlocking a closed system: dosimetric commissioning of a ring gantry linear accelerator in a multivendor environment
【2h】

Unlocking a closed system: dosimetric commissioning of a ring gantry linear accelerator in a multivendor environment

机译:解锁封闭系统:多频道环境中环形龙门线性加速器的剂量调试

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Halcyon™ platform is self‐contained, combining a treatment planning (Eclipse) system TPS) with information management and radiation delivery components. The standard TPS beam model is configured and locked down by the vendor. A portal dosimetry‐based system for patient‐specific QA (PSQA) is also included. While ensuring consistency across the user base, this closed model may not be optimal for every department. We set out to commission independent TPS (RayStation 9B, RaySearch Laboratories) and PSQA (PerFraction, Sun Nuclear Corp.) systems for use with the Halcyon linac. The output factors and PDDs for very small fields (0.5 × 0.5 cm2) were collected to augment the standard Varian dataset. The MLC leaf‐end parameters were estimated based on the various static and dynamic tests with simple model fields and honed by minimizing the mean and standard deviation of dose difference between the ion chamber measurements and RayStation Monte Carlo calculations for 15 VMAT and IMRT test plans. Two chamber measurements were taken per plan, in the high (isocenter) and lower dose regions. The ratio of low to high doses ranged from 0.4 to 0.8. All percent dose differences were expressed relative to the local dose. The mean error was 0.0 ± 1.1% (TG119‐style confidence limit ± 2%). Gamma analysis with the helical diode array using the standard 3%Global/2mm criteria resulted in the average passing rate of 99.3 ± 0.5% (confidence limit 98.3%–100%). The average local dose error for all detectors across all plans was 0.2% ± 5.3%. The ion chamber results compared favorably with our recalculation with Eclipse and PerFraction, as well as with several published Eclipse reports. Dose distribution gamma analysis comparisons between RayStation and PerFraction with 2%Local/2mm criteria yielded an average passing rate of 98.5% ± 0.8% (confidence limit 96.9%–100%). It is feasible to use the Halcyon accelerator with independent planning and verification systems without sacrificing dosimetric accuracy.
机译:Halcyon™平台自包含,将治疗计划(Eclipse)系统TPS与信息管理和辐射输送组件相结合。标准TPS光束模型配置并由供应商锁定。还包括一种用于患者特异性QA(PSQA)的基于门户的基于剂量的系统。在确保用户群中的一致性中,此封闭式模型可能对每个部门都不是最佳的。我们向委员会独立TPS(Raystation 9B,Raysearch实验室)和PSQA(Perfraction,Sun核核公司)系统进行了与Halcyon Linac一起使用。收集非常小字段(0.5×0.5cm2)的输出因子和PDD,以增加标准Varian数据集。基于具有简单模型领域的各种静态和动态测试的MLC叶片参数估计,并通过最小化离子室测量和射线蒙特卡罗计算的均值和标准偏差为15 VMAT和IMRT测试计划磨损。每次计划进行两个腔室测量,在高(Iscenter)和较低剂量区域中进行。低至高剂量的比率范围为0.4至0.8。所有百分比剂量差异相对于局部剂量表达。平均误差为0.0±1.1%(TG119式置信限度±2%)。使用标准3%全球/ 2mm标准的螺旋二极管阵列的Gamma分析导致平均通过99.3±0.5%(置信限度98.3%-100%)。所有计划的所有探测器的平均局部剂量误差为0.2%±5.3%。离子室结果有利地与我们的重新计算相比,以日食和完善,以及一些公布的Eclipse报告。剂量分布伽马分析射线和完善之间的比较,具有2%/ 2mm标准的平均通过率为98.5%±0.8%(置信限96.9%-100%)。使用具有独立规划和验证系统的Halcyon Accelerator是可行的,而不会牺牲剂量测定精度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号